Methocarbamol and Clindamycin phosphate drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Methocarbamol (methocarbamol) and Clindamycin phosphate (clindamycin phosphate). Common drug interactions include blindness among females and anhedonia among males.
The phase IV clinical study analyzes what interactions people have when they take Methocarbamol and Clindamycin phosphate. It is created by eHealthMe based on reports of 26 people who take the same drugs from the FDA, and is updated regularly.
What is Methocarbamol?
Methocarbamol has active ingredients of methocarbamol. It is often used in muscle spasms. eHealthMe is studying from 17,766 Methocarbamol users. Check the latest studies of Methocarbamol.
What is Clindamycin phosphate?
Clindamycin phosphate has active ingredients of clindamycin phosphate. It is often used in infection. eHealthMe is studying from 4,216 Clindamycin phosphate users. Check the latest studies of Clindamycin phosphate.
26 people who take Methocarbamol and Clindamycin phosphate together, and have interactions are studied.

What are the common drug interactions of Methocarbamol and Clindamycin Phosphate, by gender? *:
female:
- Blindness
- Gastritis (inflammation of stomach)
- Hypoxia (low oxygen in tissues)
- Pain in extremity
- Restless legs syndrome (a powerful urge to move your legs)
- Sexual dysfunction (difficulty experienced by an individual or a couple during any stage of a normal sexual activity)
- Abdominal pain upper
- Adverse drug reaction
- Anxiety
- Arthralgia (joint pain)
male:
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Anxiety
- Nausea (feeling of having an urge to vomit)
- Osteonecrosis (death of bone)
- Pleural effusion (water on the lungs)
- Pyrexia (fever)
- Staphylococcal infection (an infection with staphylococcus bacteria)
- Dyspnoea (difficult or laboured respiration)
- Pneumonia
- Abdominal discomfort
What are the common drug interactions of Methocarbamol and Clindamycin Phosphate, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
- Asthma
- Death
- Nausea (feeling of having an urge to vomit)
- Pleural effusion (water on the lungs)
- Pyrexia (fever)
- Staphylococcal infection (an infection with staphylococcus bacteria)
30-39:
- Dyspnoea (difficult or laboured respiration)
- Pneumonia
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Anxiety
- Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
- Depression
- Fear of disease
- Pain in extremity
- Pulmonary embolism (blockage of the main artery of the lung)
40-49:
- Hysterectomy
50-59:
- Emotional distress
- Multiple fractures
- Osteoporosis (bones weak and more likely to break)
- Tooth loss
- Bone loss
- Osteonecrosis (death of bone)
- Abdominal pain upper
- Anaphylactic reaction (serious allergic reaction)
- Apnoea (suspension of external breathing)
- Arthralgia (joint pain)
60+:
- Blindness
- Arthritis (form of joint disorder that involves inflammation of one or more joints)
- Memory impairment
- Age-related macular degeneration
- Cataract (clouding of the lens inside the eye)
- Irritability
What are the existing conditions these people have? *
- Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 8 people, 30.77%
- Cataplexy (loss of muscle tone accompanied by full conscious awareness): 8 people, 30.77%
- Depression: 6 people, 23.08%
- Pain: 5 people, 19.23%
- Constipation: 4 people, 15.38%
- Bacterial Infection: 4 people, 15.38%
- Trigeminal Neuralgia (a painful condition of the nerve responsible for most facial sensation): 3 people, 11.54%
- Skin Ulcer: 3 people, 11.54%
- Hiv Infection: 3 people, 11.54%
- Fungal Infection: 3 people, 11.54%
* Approximation only. Some reports may have incomplete information.
Do you take Methocarbamol and Clindamycin phosphate?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Methocarbamol (17,766 reports)
- Clindamycin phosphate (4,216 reports)
Browse all drug interactions of Methocarbamol and Clindamycin phosphate:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Methocarbamol:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Clindamycin phosphate:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Methocarbamol and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Clindamycin phosphate and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on methocarbamol and clindamycin phosphate (the active ingredients of Methocarbamol and Clindamycin phosphate, respectively), and Methocarbamol and Clindamycin phosphate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Cimetidine and Duloxetine Hydrochloride - 2 seconds ago
- Drug interactions of Hydrocodone Bitartrate And Acetaminophen and Bextra - 6 seconds ago
- Could Angeliq cause Breast Pain? - 16 seconds ago
- Could Sensipar cause Gingival Disorder? - 17 seconds ago
- Drug interactions of Valsartan and Tivicay - 20 seconds ago
- Drug interactions of Hydrocodone Bitartrate And Acetaminophen and Alkeran - 21 seconds ago
- Drug interactions of Qvar and Felodipine - 42 seconds ago
- Could Amlodipine Besylate cause Gingivitis? - 43 seconds ago
- Cardiac Failure Congestive and Anorexia - 55 seconds ago
- Could Romazicon cause Stress And Anxiety? - 58 seconds ago